Washington University Center for Translational Neuroscience
Washington University Center for Translational Neuroscience
批准号:
8334855
负责人:
DAVID M. HOLTZMAN
金额:
$76.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-25 至 2013-08-31
关键词:
Alzheimer&aposs DiseaseBiological PhenomenaBrain imagingCancer Center Support GrantClinical DataClinical ResearchCollaborationsCommunitiesDevelopmentDiagnosticDiseaseEnvironmentFundingGoalsGrantHuman ResourcesIndividualInformaticsLaboratoriesMental disordersMolecular AnalysisNational Institute of Neurological Disorders and StrokeNeurobiologyNeurologicNeurosciencesResearchResearch InfrastructureResearch PersonnelResource DevelopmentResourcesSchizophreniaTechnical ExpertiseTechnologyTherapeuticTranslatingTranslationsUnited States National Institutes of HealthUniversitiesViral VectorWashingtonWorkcostdata acquisitionnervous system disordernovel diagnosticsnovel therapeuticsoptical imagingpre-clinicaltranslational neuroscience
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overarching goal of this grant, entitled "Washington University Center for Translational Neuroscience- WUCTN" is to support centralized resources, facilities, and expertise shared by neuroscience investigators at Washington University in order to facilitate discovery of fundamental mechanisms of disorders of the nervous system and to translate this understanding into treatments and cures. Core A, Administration, will organize and facilitate interaction among the 6 other cores: Core B, Biospecimen and Clinical Data Acquisition; Core C, Molecular Analysis; Core D, Viral Vectors; Core E, Optical imaging; Core F, Functional Assessment; and Core G, Informatics. By pooling and organizing resources and expertise, the enormous breadth and collaborative spirit of the Washington University neuroscience community that spans virtually every department, can take advantage of economies of scale, confront challenges too large for individual investigators, and develop an infrastructure that will serve the user group of over 120 investigators. The WUCTN will capitalize on the development and resources of 3 new initiatives at Washington University: Biomed 21, the Hope Center for Neurological Disorders, and the Neurological Clinical Research Unit as well as utilize the support and expertise of the long established McDonnell Neuroscience Centers to assist in supporting the personnel and infrastructure being requested in this proposal. In addition, we will work together with several ongoing NIH funded centers at Washington University including the Alzheimer's Disease Research Center, the Conte Center for research on the neurobiology of schizophrenia, and the NINDS Center Core for Brain Imaging to add "extra value" to this proposal. The increasing complexity and cost of the technologies required to characterize biological phenomenon are often beyond the expertise and resources of an individual laboratory. This makes it very difficult to establish and validate key new discoveries in a cohesive, timely, and cost-efficient manner without access to facilities specializing in these enabling technologies. The proposed Core infrastructure, situated within the collaborative environment that exists between the basic neurosciences and the neurobiology of disease community at Washington University, will help catalyze a strong translational effort to convert basic discoveries into diagnostic and therapeutic advances. This will be manifested as: 1) greater efficiency in utilizing enabling technologies by individual investigators; 2) greater collaboration aimed at pre-clinical development of potential therapeutic strategies; and, 3) faster translation of initial discoveries into useful treatments for disorders of the nervous system.
期刊论文(61)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/ana.23793
发表时间:
2013-02
期刊:
ANNALS OF NEUROLOGY
影响因子:
11.2
作者:
[Diggs-Andrews, Kelly A., Tokuda, Kazuhiro, Izumi, Yukitoshi, Zorumski, Charles F., Wozniak, David F., Gutmann, David H.]
通讯作者:
Gutmann, David H.
DOI:
10.3109/14767058.2014.921152
发表时间:
2015-03
期刊:
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
影响因子:
--
作者:
[Stout MJ, Cao B, Landeau M, French J, Macones GA, Mysorekar IU]
通讯作者:
Mysorekar IU
Mapping kidney tubule diameter ex vivo by diffusion MRI.
通过扩散 MRI 绘制离体肾小管直径。
DOI:
10.1152/ajprenal.00369.2020
发表时间:
2021
期刊:
American journal of physiology. Renal physiology
影响因子:
--
作者:
[Morozov,Darya, Parvin,Neda, Charlton,JenniferR, Bennett,KevinM]
通讯作者:
Bennett,KevinM
DOI:
10.3390/behavsci1010004
发表时间:
2011-12-30
期刊:
Behavioral sciences (Basel, Switzerland)
影响因子:
--
作者:
[Maloney SE, Noguchi KK, Wozniak DF, Fowler SC, Farber NB]
通讯作者:
Farber NB
DOI:
10.1016/j.neuroimage.2017.03.059
发表时间:
2017-06
期刊:
NeuroImage
影响因子:
5.7
作者:
[Gangolli M, Holleran L, Hee Kim J, Stein TD, Alvarez V, McKee AC, Brody DL]
通讯作者:
Brody DL
共 32 条
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics
-
批准号:10674679
-
项目类别:
-
资助金额:$62.0万
-
财政年份:2022
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
APOE effects on glial lipid metabolism and 25-hydroxycholesterol: Effects on aging and AD-related pathology
-
批准号:10667466
-
项目类别:
-
资助金额:$53.02万
-
财政年份:2021
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
APOE effects on glial lipid metabolism and 25-hydroxycholesterol: Effects on aging and AD-related pathology
-
批准号:10407944
-
项目类别:
-
资助金额:$54.01万
-
财政年份:2021
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Administration Core
-
批准号:10622634
-
项目类别:
-
资助金额:$80.27万
-
财政年份:2020
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:10622633
-
项目类别:
-
资助金额:$307.63万
-
财政年份:2020
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Sleep and Circadian Rhythms in Alzheimer Disease: Potential bi-directional relationship with tau
-
批准号:9815588
-
项目类别:
-
资助金额:$369.43万
-
财政年份:2019
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Nervous System Development and Injury
-
批准号:9386458
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2016
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Novel Strategies and Mechanisms to Target APOE and Alzheimer's Disease
-
批准号:8779836
-
项目类别:
-
资助金额:$59.46万
-
财政年份:2014
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Novel Strategies and Mechanisms to Target APOE and Alzheimer's Disease
-
批准号:9060227
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2014
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Novel Strategies and Mechanisms to Target APOE and Alzheimer's Disease
-
批准号:9814735
-
项目类别:
-
资助金额:$376.01万
-
财政年份:2014
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Administrative Core
-
批准号:10006905
-
项目类别:
-
资助金额:$7.01万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Regional, Synpatic, Cellular Modulation of Abeta Metabolism
-
批准号:8642679
-
项目类别:
-
资助金额:$112.94万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Dynamic Regulation of Amyloid-^ in the CNS
-
批准号:8331629
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Regional, Synpatic, Cellular Modulation of Abeta Metabolism
-
批准号:8838268
-
项目类别:
-
资助金额:$112.94万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Effects of the Sleep/Wake Cycle on A-Beta, Tau and Spreading
-
批准号:10006907
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Neuronal LRP1 and HSPG in Pathological Spreading of A-Beta and Tau
-
批准号:10246278
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Neuronal LRP1 and HSPG in Pathological Spreading of A-Beta and Tau
-
批准号:10006909
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Administrative Core
-
批准号:10246274
-
项目类别:
-
资助金额:$6.79万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Regional, Synpatic, Cellular Modulation of Abeta Metabolism
-
批准号:8467068
-
项目类别:
-
资助金额:$110.69万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
Regional, Synaptic, Cellular Modulation of Abeta Metabolism
-
批准号:9764499
-
项目类别:
-
资助金额:$146.62万
-
财政年份:2012
-
负责人:DAVID M. HOLTZMAN
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: